The analysis of EV-associated DNA can reveal geneticalterationsassociated with pancreatic cancer and aid in diagnosis and monitoring.Studies indicate that approximately 40% of EVs derived from PDAC cellscontain mutations in KRAS and/or p53. This evidence concerns the gene KRAS and pancreatic neoplasm.